Product NDC: | 0173-0393 |
Proprietary Name: | ZANTAC |
Non Proprietary Name: | ranitidine hydrochloride |
Active Ingredient(s): | 300 mg/1 & nbsp; ranitidine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0393 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018703 |
Marketing Category: | NDA |
Start Marketing Date: | 19891001 |
Package NDC: | 0173-0393-40 |
Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (0173-0393-40) |
NDC Code | 0173-0393-40 |
Proprietary Name | ZANTAC |
Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (0173-0393-40) |
Product NDC | 0173-0393 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ranitidine hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19891001 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | RANITIDINE HYDROCHLORIDE |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |